Overall, although our results with cell culture do not demonstrate the feasibility of decreasing extracellular Mg2+ concentration to increase R132H IDH1 inhibition, there would seem to be scope for further exploration of metal ion therapy (including potentially via diet therapy and/or circadian control39) for cancer treatment, including with respect to IDH variants. This evidence concerns the gene IDH2 and cancer.